Clinical Trial Update: Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial exploring capecitabine with radiation followed by durvalumab as preoperative treatment for rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Durvalumab (durvalumab)

Snippet

Sponsor: AUSL Romagna Rimini | Conditions: RECTAL CANCER | Phase 2 | Status: UNKNOWN